← Leaderboards
Robin R Deterding
University Of Colorado Denver
$72,089
Attributed
$72,089
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $17.7K · FY2006–07$20K$15K$10K$5K$0
'06
'07
Funding mix
By agency
NIH$72,089 · 4
By mechanism
M01$42,089 · 3
R13$30,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Thomas E Finger$17,925,157
- Sue Kinnamon$17,923,672
- Raphael A. Nemenoff$15,000,654
- Myra L Muramoto$12,138,633
- Stanley J Szefler$16,550,328
Others in their field
Top investigators on “Cystic Fibrosis”
- John F Engelhardt · University Of Iowa$42,933,706
- Michael R Knowles · University Of North Carolina Chapel Hill$30,250,682
- David A Stoltz · University Of Iowa$25,455,359
- Joseph Zabner · University Of Iowa$25,382,103
- Paul B McCray · University Of Iowa$25,146,293
- Richard C Boucher · University Of North Carolina Chapel Hill$24,890,955
Research focus
Cystic FibrosisAirway Surface LiquidChloride IonBiological Fluid TransportBreathingBypassBaseChronicClassClinical ResearchClinical Trials, Phase IiiComputer Retrieval Of Information On Scientific Projects DatabaseAirway EpitheliumCystic Fibrosis PatientsCystic Fibrosis, PulmonaryCystic Fibrosis Transmembrane Conductance RegulatorDailyDenufosol TetrasodiumDouble-Blind MethodEarly Intervention (Education)Frequencies (Time Pattern)Functional DisorderFundingAgonist
Grant awards (4)
EFFICACY AND SAFETY OF DENUFOSOL TETRASODIUM (INS37217) INHALATION SOLUTION$17,718
M01 · FY2007 · RR · contact PI
DENUFOSOL TETRASODIUM INHALATION SOLUTION IN PATIENTS WITH CF LUNG DISEASE$6,481
M01 · FY2006 · RR · contact PI
Pediatric Interstitial Lung Disease Conference$30,000
R13 · FY2004 · HL
Inhalation Solution in Subjects with Mild to Moderate CF$17,890
M01 · FY2004 · RR